The mutation landscape plot revealed the presence of prominent genes such as TP53, KRAS, CTNNB1, and SMAD4 in LIHC and PAAD, which are known to promote tumor initiation and development (Figure 5D). This evidence concerns the gene KRAS and neoplasm.